Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride may be safer than oral finasteride, but more research is needed.

The combination of finasteride and minoxidil is as safe and effective as minoxidil alone for improving hair growth in men.

Expanding premarital screening to include skin conditions, STDs, infertility, and male disorders can improve marriage stability.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

The combination of finasteride, dutasteride, and minoxidil is generally safe for treating male hair loss with minimal side effects.

Low-dose dutasteride effectively and safely promotes hair growth in men.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.

Finasteride has various adverse effects, including sexual dysfunction and mental health issues, which vary by age and gender.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Finasteride treatment may cause erectile dysfunction, but stopping it reverses these effects.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Finasteride is more harmful to male reproductive health than minoxidil.

Many dermatologists believe finasteride can cause sexual side effects and counsel patients about them.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Men with type 2 diabetes often have low testosterone and signs of hypogonadism, especially if they are overweight.

Hair loss without scarring is more common than permanent hair loss with scarring, and is often due to genetic factors.

Premature hair whitening or loss may indicate a risk for erectile dysfunction.

Telemedicine is effective for sexual medicine consultations.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Finasteride is commonly used for male pattern hair loss but has potential risks, including irreversible sexual dysfunction.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

BPH treatments can cause sexual side effects affecting quality of life.

The meeting highlighted advances in sexual medicine and priapism management.

Cushing syndrome often causes low testosterone and sexual issues in men.